Anti-spike IgG S/Co ratio at second post-vaccination testing and COVID-19 test.
figure
posted on 2024-04-04, 17:22 authored by Lucy W. Mwangi, Geoffrey Omuse, Rodney Adam, George Ong’ete, Cyrus Matheka, Patrick Mugaine, Shahin Sayed, Daniel MainaStratified by sex (S1a) and age category (S1b) [age n = 968].
(JPG)
History
Usage metrics
Categories
Keywords
19 ), causedcoronavirus disease 19requiring hospitalisation evenalthough protective antibodies981 ), 28xlink "> followingthird vaccine doses19 disease severitykenya 18 months postxlink "> almostreceiving primary vaccinationclinical healthcare workers981 ), receivedvaccination influenced sarssecond vaccine dosexlink ">disease severityhealthcare workersthird dosevaccine testprimary vaccinationeven deathclinical hcwsalmost halfsecond dosevaccination testingvaccination sarsvaccination protectedvaccination becametested sarstertiary facilityspike antibodiessignificantly higherside effectssecond postmain strategyfindings suggestemerging sarsconsidered highblood samples
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC